2020 Best of Breast


 

Discussion on Systemic Treatment Algorithm for HR+, HER2- Recurrent Breast Cancer: Review of Approved CDK4/6 Inhibitors and Related Trials, Differences in Dosing and Safety & Managing Side Effects

58 views
March 2, 2020
Comments 0
Login to view comments. Click here to Login